Rationality for the Use of Neuromodulation in Disorders of Gut-Brain Interaction (Functional Gastrointestinal Disorders)

Authors

DOI:

https://doi.org/10.22516/25007440.997

Keywords:

Functional Gastrointestinal Disorders, neuromodulation, antidepressants

Abstract

Within the broad range of therapeutic options for managing functional gastrointestinal disorders, recently redefined as Disorders of Gut-Brain Interaction (DGBI) by the Rome Foundation in the Rome IV criteria, certain medications with antidepressant, anxiolytic, or antipsychotic effects are commonly employed. These drugs, now referred to as neuromodulators by the Rome Foundation, target the neurogastroenterological dysfunction associated with these disorders. Consequently, their clinical utility as psychiatric medications can now be leveraged to benefit patients with DGBI.

This narrative review aims to provide an updated and specific overview of the indications for neuromodulators in the primary DGBI. The first section of this review focuses on the rationale and justification for their use.

Downloads

Download data is not yet available.

Author Biographies

David Benigno Páramo Hernández, Gut médica, Instituto de salud digestiva

Gastroenterólogo y epidemiólogo clínico. Bogotá, Colombia.

Luis Fernando Pineda Ovalle , Gut Médica, Instituto de Salud Digestiva

Especialista en medicina interna, gastroenterología y epidemiología. Director Gut Médica. Bogotá, Colombia.

Laura Marcela Moya Valenzuela , Gut Médica Instituto de salud digestiva

Especialista en medicina interna y gastroenterología. Gastromedicall, Clinica de la Colina y GutMédica. Bogotá, Colombia.

Alejandro Concha Mejía , Clínica El Country

Médico y cirujano, especialista en medicina interna, especialista en gastroenterología y epidemiología. Jefe de gastroenterología. Bogotá, Colombia.

References

Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257-61. https://doi.org/10.1053/j.gastro.2016.03.035

Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, van Oudenhove L. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Gastroenterology. 2018;154(4):1140-1171.e1. https://doi.org/10.1053/j.gastro.2017.11.279

Vanner SJ, Greenwood-Van Meerveld B, Mawe GM, Shea-Donohue T, Verdu EF, Wood J, et al. Fundamentals of Neurogastroenterology: Basic Science. Gastroenterology. 2016;150(6):1280-91. https://doi.org/10.1053/j.gastro.2016.02.018

Abdullah N, Defaye M, Altier C. Neural control of gut homeostasis. Am J Physiol Gastrointest Liver Physiol. 2020;319(6):G718-G732. https://doi.org/10.1152/ajpgi.00293.2020

Jin P, Jan LY, Jan YN. Mechanosensitive Ion Channels: Structural Features Relevant to Mechanotransduction Mechanisms. Annu Rev Neurosci. 2020;43:207-29. https://doi.org/10.1146/annurev-neuro-070918-050509

Kiela PR, Ghishan FK. Physiology of Intestinal Absorption and Secretion. Best Pract Res Clin Gastroenterol. 2016;30(2):145-59. https://doi.org/10.1016/j.bpg.2016.02.007

Spencer NJ, Hu H. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 2020;17(6):338-51. https://doi.org/10.1038/s41575-020-0271-2

Foong D, Zhou J, Zarrouk A, Ho V, O’Connor MD. Understanding the Biology of Human Interstitial Cells of Cajal in Gastrointestinal Motility. Int J Mol Sci. 2020;21(12):1-18. https://doi.org/10.3390/ijms21124540

Greenwood-Van Meerveld B, Johnson AC. Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin. Frontiers in Systems Neuroscience. 2017;11:86. https://doi.org/10.3389/fnsys.2017.00086

Elam JS, Glasser MF, Harms MP, Sotiropoulos SN, Andersson JLR, Burgess GC, et al. The Human Connectome Project: A retrospective. Neuroimage. 2021;244:118543. https://doi.org/10.1016/j.neuroimage.2021.118543

Kano M, Grinsvall C, Ran Q, Dupont P, Morishita J, Muratsubaki T, et al. Resting state functional connectivity of the pain matrix and default mode network in irritable bowel syndrome: a graph theoretical analysis. Scientific Reports. 2020;10(1):11015. https://doi.org/10.1038/s41598-020-67048-9

Turkiewicz J, Bhatt RR, Wang H, Vora P, Krause B, Sauk JS, et al. Altered brain structural connectivity in patients with longstanding gut inflammation is correlated with psychological symptoms and disease duration. Neuroimage Clin. 2021;30:102613. https://doi.org/10.1016/j.nicl.2021.102613

Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil. 2008;20 (Suppl 1):73-80. https://doi.org/10.1111/j.1365-2982.2008.01110.x

Piche T. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014;26(3):296-302. https://doi.org/10.1111/nmo.12315

Boyer J, Saint-Paul MC, Dadone B, Patouraux S, Vivinus MH, Ouvrier D, et al. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil. 2018;30(1). https://doi.org/10.1111/nmo.13223

Hong JY, Labus JS, Jiang Z, Ashe-Mcnalley C, Dinov I, Gupta A, et al. Regional neuroplastic brain changes in patients with chronic inflammatory and non-inflammatory visceral pain. PLoS One. 2014;9(1):e84564. https://doi.org/10.1371/journal.pone.0084564

Mills EP, Keay KA, Henderson LA. Brainstem Pain-Modulation Circuitry and Its Plasticity in Neuropathic Pain: Insights From Human Brain Imaging Investigations. Frontiers in pain research (Lausanne, Switzerland). 2021;2:705345. https://doi.org/10.3389/fpain.2021.705345

van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, et al. Biopsychosocial Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016;150(6):1355-1367.e2. https://doi.org/10.1053/j.gastro.2016.02.027

Drossman DA. Abuse, trauma, and GI illness: is there a link? Am J Gastroenterol. 2011;106(1):14-25. https://doi.org/10.1038/ajg.2010.453

Bouchoucha M, Hejnar M, Devroede G, Babba T, Bon C, Benamouzig R. Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: a gender issue? Clin Res Hepatol Gastroenterol. 2013;37(4):422-30. https://doi.org/10.1016/j.clinre.2012.10.011

Dimsdale JE, Creed F, Escobar J, Sharpe M, Wulsin L, Barsky A, et al. Somatic symptom disorder: an important change in DSM. J Psychosom Res. 2013;75(3):223-8. https://doi.org/10.1016/j.jpsychores.2013.06.033

Radu M, Moldovan R, Pintea S, Băban A, Dumitrașcu D. Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis. J Gastrointestin Liver Dis. 2018;27(3):257-63. https://doi.org/10.15403/jgld.2014.1121.273.bab

Figure 1. Afferent neural pathways in the DGBI(2). Modified with permission from: Drossman DA et al. Gastroenterology. 2018;154(4):1140-1171.e1.

Published

2023-06-22

How to Cite

Páramo Hernández, D. B., Pineda Ovalle , L. F., Moya Valenzuela , L. M., & Concha Mejía , A. (2023). Rationality for the Use of Neuromodulation in Disorders of Gut-Brain Interaction (Functional Gastrointestinal Disorders). Revista Colombiana De Gastroenterología, 38(2), 180–187. https://doi.org/10.22516/25007440.997

Issue

Section

Review articles

Altmetric

Crossref Cited-by logo
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code